batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Revolution in the next KRAS battleground 20 September 2023 The bad news just keeps coming for Kinnate 19 September 2023 Bayer looks to clinical validation for $1.5bn Vividion deal 18 September 2023 Europe sinks Blenrep 15 September 2023 World Lung 2023 – Impower-151 can’t repeat Impower-150’s lung cancer success 11 September 2023 World Lung 2023 – some support for TROP2 combos in first-line lung cancer 11 September 2023 Mariposa-2 might give J&J confidence in lazertinib 6 September 2023 ESMO 2023 preview – conjugates, bispecifics and more 4 September 2023 Load More